Go to content
Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 10 jun 2015 - 16:30
Statutaire naam Vivoryon Therapeutics N.V.
Titel Probiodrug: Annual General Meeting and Election of New Supervisory Board members
Bericht Annual General Meeting of Probiodrug AG Election of New Supervisory Board members HALLE/SAALE, Germany, 10 June, 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), has the honour to announce the following Supervisory Board changes following its Annual General Meeting (AGM) held on 10 June 2015. The shareholders have elected Ms Charlotte Lohmann and Mr Kees Been as new members of the Supervisory Board.